Skip to main content

Successful Weight Loss in Two Adult Patients Diagnosed with Late-Onset Long-Chain Fatty Acid Oxidation Defect

  • Case Report
  • Chapter
  • First Online:

Part of the book series: JIMD Reports ((JIMD,volume 6))

Abstract

Patients with long-chain fatty acid oxidation defect (LCFAOD) cannot tolerate fasting and are restricted in their physical activity, hence their increased risk of obesity. Experts therefore advise avoidance of catabolic situations and discourage weight reduction in these patients.

Two patients with late-diagnosed LCFAOD undergoing treatment at two academic centers successfully lost weight under supervision of a metabolic dietitian. Patient 1 (male, 47 years) diagnosed with CPT 2 deficiency lost 10 kg body weight in a 3-month period with the help of an energy and LCT-restricted, MCT- and carbohydrate-rich diet in combination with an exercise program. CK levels, C16, C18, and C18:1 levels of his acylcarnitine profile and his blood pressure decreased during the period of weight reduction. Patient 2 (male, 39 years) has a VLCAD deficiency. Dietary advice was energy and LCT restriction, MCT and carbohydrate-enriched food with raw cornstarch added during the night. Patient 2 lost almost 40 kg body weight to 87.6 kg (BMI 25.1) in 2 years. CK, insulin, TG, and ALAT blood levels decreased. Conclusion: Weight reduction without loss of metabolic control seems possible in late-onset LCFAOD patients. No metabolic crisis occurred in these two patients, while the positive effects of weight reduction were clear. The residual enzyme function in late-onset LCFAOD may be one of the reasons that metabolic decompensation was prevented. In addition, dietary adjustments to prevent excessive fatty acid oxidation likely contributed as well. Therefore, expert supervision by a dietician specialized in metabolic diseases is recommended.

Concise SentenceContrary to the current literature, weight loss in patients with late-diagnosed LCFAOD can be successful. A description of two FOAD patients who lost weight without encountering negative side effects at two academic centers is given.

Competing interests: None declared

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Abbreviations

ALAT:

Alanine-aminotransferase

BMI:

Body mass index

BP:

Blood pressure

CK:

Creatine kinase

CPT 2:

Carnitine palmitoyl-CoA transferase 2

FAOD:

Fatty acid oxidation defect

LCFAOD:

Long-chain fatty acid oxidation defect

LCT:

Long-chain triglycerides (long-chain fat)

MCT:

Medium-chain triglycerides

TG:

Triglycerides (fat)

VLCAD:

Very long-chain acyl-CoA dehydrogenase

References

  • Behrend AM, Harding CO, Shoemaker JD, Matern D, Sahn DJ, Elliot DL, Gillingham MB (2011) Substrate oxidation and cardiac performance during exercise in disorders of long chain fatty acid oxidation. Mol Genet Metab 105(2012):110–115

    Google Scholar 

  • Gillingham MB, Purnell JQ, Jordan J, Stadler D, Haqq AM, Harding CO (2007) Effects of higher dietary protein intake on energy balance and metabolic control in children with long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiency. Mol Genet Metab 90(1):64–69

    Article  PubMed  CAS  Google Scholar 

  • Laforêt P, Vianey-Saban C (2010) Disorders of muscle lipid metabolism: diagnostic and therapeutic challenges. Neuromuscul Disord 11:693–700

    Article  Google Scholar 

  • Roza AM, Shizgal HM (1984) The Harris Benedict reevaluated: resting energy requirement and body cell mass. Am J Clin Nutr 40:168–182

    PubMed  CAS  Google Scholar 

  • Spiekerkoetter U et al (2009) Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop. J Inherit Metab Dis 32:498–505

    Article  PubMed  CAS  Google Scholar 

  • Spiekerkoetter U et al (2010) Current issues regarding treatment of mitochondrial fatty acid oxidation disorders. J Inherit Metab Dis 33:555–561

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. Zweers .

Editor information

Editors and Affiliations

Additional information

Communicated by: Jerry Vockley

Rights and permissions

Reprints and permissions

Copyright information

© 2012 SSIEM and Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Zweers, H., Timmer, C., Rasmussen, E., den Heijer, M., de Valk, H. (2012). Successful Weight Loss in Two Adult Patients Diagnosed with Late-Onset Long-Chain Fatty Acid Oxidation Defect. In: JIMD Reports - Case and Research Reports, 2012/3. JIMD Reports, vol 6. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2012_131

Download citation

  • DOI: https://doi.org/10.1007/8904_2012_131

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-28128-0

  • Online ISBN: 978-3-642-28129-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics